ID   HPE-15
AC   CVCL_WL66
SY   Human Prostate Epithelial-15
DR   Wikidata; Q94217176
RX   PubMed=31020641;
CC   Doubling time: ~31 hours (PubMed=31020641).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): PubMed=31020641
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 10,13
ST   D8S1179: 14,15
ST   FGA: 19,25
ST   Penta D: 12,13
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL64 ! HPS-14
OI   CVCL_WL65 ! HPS-15
SX   Male
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
RX   PubMed=31020641; DOI=10.1002/ijc.32370; PMCID=PMC6703920;
RA   Wang, Ruo-Xiang
RA   Chu, Gina C.-Y.
RA   Wang, Xu-Dong
RA   Wu, Jason B.
RA   Hu, Pei-Zhen
RA   Multani, Asha S.
RA   Pathak, Sen
RA   Zhau, Hai-Yen E.
RA   Chung, Leland W.K.
RT   "Establishment and characterization of a prostate cancer cell line
RT   from a prostatectomy specimen for the study of cellular interaction.";
RL   Int. J. Cancer 145:2249-2259(2019).
//